ScientistUniversity of California, San FrancicsoSan Franscisco, California, United States
OC 39.2 - Development of antibodies to disrupt FXIII/fibrinogen interactions for venous thrombosis prevention
Monday, June 24, 202409:45 - 10:00 ICT